Did you mean filorexant of mk 6469 of フィロレキサント?
Displaying drugs 101 - 125 of 135 in total
MK-0767
MK0767 has been used in trials studying the treatment of Dyslipidemia, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type II, among others.
Investigational
Matched Name: … MK-0767 …
MK-5108
MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.
Investigational
Matched Name: … MK-5108 …
Matched Description: … MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors. …
Matched Description: … MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors. …
MK-6186
MK6186 has been used in trials studying the treatment of HIV-1 Infection.
Investigational
Matched Name: … MK-6186 …
MK-0873
MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Name: … MK-0873 …
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
MK-1454
A synthetic cyclic dinucleotide (CDN) and agonist of stimulator of interferon genes protein (STING), with potential immunoactivating and antineoplastic activities. Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway, which promotes IKK-related kinase TANK-binding kinase 1 (TBK1) signaling and activates nuclear factor-kappa B (NF-kB)...
Investigational
Matched Name: … MK-1454 …
Matched Description: … Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway …
Matched Description: … Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway …
MK-6325
MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)).
Investigational
Matched Name: … MK-6325 …
Matched Description: … of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)). ... MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics …
Matched Description: … of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)). ... MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics …
MK-0773
MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)).
Investigational
Matched Name: … MK-0773 …
Matched Description: … MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK ... -0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)). …
Matched Description: … MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK ... -0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)). …
MK-212
MK-212 has been used in trials studying the treatment of Alcoholism.
Investigational
Matched Name: … MK-212 …
Matched Description: … MK-212 has been used in trials studying the treatment of Alcoholism. …
Matched Salts name: … MK-212 hydrochloride …
Matched Description: … MK-212 has been used in trials studying the treatment of Alcoholism. …
Matched Salts name: … MK-212 hydrochloride …
MK-4721
MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell Antigen (PSCA), an antigen expressed at significant levels on tumor cells from the majority of patients with all stages of prostate, pancreatic and bladder cancers.
Investigational
Matched Name: … MK-4721 …
Matched Description: … MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell …
Matched Description: … MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell …
MK-0731
MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent.
Experimental
Matched Name: … MK-0731 …
Matched Description: … MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent. …
Matched Description: … MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent. …
MK-8776
Sch 900776 has been used in trials studying the treatment of Neoplasms, Hodgkin Disease, Adult Erythroleukemia, Lymphoma, Non-Hodgkin, and Myelogenous Leukemia, Acute, among others.
Investigational
Matched Name: … MK-8776 …
MK-0249
MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
Investigational
Matched Name: … MK-0249 …
MK-0777
MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.
Investigational
Matched Name: … MK-0777 …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
MK-1496
MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
Investigational
Matched Name: … MK-1496 …
Matched Description: … MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant. …
Matched Description: … MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant. …
MK-0752
Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).
Investigational
Matched Name: … MK-0752 …
Matched Description: … Recurrent or Refractory CNS Cancer). ... Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With …
Matched Description: … Recurrent or Refractory CNS Cancer). ... Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With …
MK-7622
MK-7622 has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Name: … MK-7622 …
Matched Description: … MK-7622 has been used in trials studying the treatment of Alzheimer's Disease. …
Matched Description: … MK-7622 has been used in trials studying the treatment of Alzheimer's Disease. …
MK-0533
MK-0533 is under investigation in clinical trial NCT00543959 (Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)).
Investigational
Matched Name: … MK-0533 …
Matched Description: … MK-0533 is under investigation in clinical trial NCT00543959 (Efficacy and Tolerability of MK0533 in …
Matched Description: … MK-0533 is under investigation in clinical trial NCT00543959 (Efficacy and Tolerability of MK0533 in …
MK-0482
MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
Matched Name: … MK-0482 …
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
MK-4830
MK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT) 4 receptor.
Investigational
Matched Name: … MK-4830 …
Matched Description: … MK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT …
Matched Description: … MK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT …
Dalotuzumab
Dalotuzumab has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.
Investigational
Matched Synonyms: … MK-0646 …
Actoxumab
Actoxumab is under investigation in clinical trial NCT01241552 (A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)).
Investigational
Matched Description: … Actoxumab is under investigation in clinical trial NCT01241552 (A Study of MK-3415, MK-6072, and MK-3415A ... in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)). …
Uprifosbuvir
Uprifosbuvir is under investigation in clinical trial NCT02332707 (Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)).
Investigational
Matched Description: … -5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis ... C Genotype (GT)1 and GT2 Infection (MK-3682-011)). ... Uprifosbuvir is under investigation in clinical trial NCT02332707 (Efficacy and Safety of Grazoprevir (MK …
Quavonlimab
Quavonlimab is under investigation in clinical trial NCT03179436 (Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)).
Investigational
Matched Description: … With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)). ... Quavonlimab is under investigation in clinical trial NCT03179436 (Study of Quavonlimab (MK-1308) in Combination …
Birabresib
Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)).
Investigational
Matched Description: … in Participants With Selected Advanced Solid Tumors (MK-8628-006)). ... Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 …
Displaying drugs 101 - 125 of 135 in total